Biosensor-based assay of exosome biomarker for early diagnosis of cancer

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 157-175 doi:10.1007/s11684-021-0884-z

Abstract 130 PDF 32

Paternal environmental exposure-induced spermatozoal small noncoding RNA alteration meditates the intergenerational epigenetic inheritance of multiple diseases

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 176-184 doi:10.1007/s11684-021-0885-y

Abstract 226 PDF 28

SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 185-195 doi:10.1007/s11684-021-0913-y

Abstract 57 PDF 30

SARS-CoV-2 variants, immune escape, and countermeasures

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 196-207 doi:10.1007/s11684-021-0906-x

Abstract 69 PDF 27

Multi-target combinatory strategy to overcome tumor immune escape

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 208-215 doi:10.1007/s11684-022-0922-5

Abstract 97 PDF 27

Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 216-226 doi:10.1007/s11684-022-0920-7

Abstract 96 PDF 26

Cannabidiol prevents depressive-like behaviors through the modulation of neural stem cell differentiation

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 227-239 doi:10.1007/s11684-021-0896-8

Abstract 145 PDF 24

Accurate quantification of 3′-terminal 2′-O-methylated small RNAs by utilizing oxidative deep sequencing and stem-loop RT-qPCR

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 240-250 doi:10.1007/s11684-021-0909-7

Abstract 101 PDF 30

PathogenTrack and Yeskit: tools for identifying intracellular pathogens from single-cell RNA-sequencing datasets as illustrated by application to COVID-19

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 251-262 doi:10.1007/s11684-021-0915-9

Abstract 197 PDF 22

Integrated analysis of gut microbiome and host immune responses in COVID-19

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 263-275 doi:10.1007/s11684-022-0921-6

Abstract 95 PDF 24

Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 276-284 doi:10.1007/s11684-021-0855-4

Abstract 123 PDF 23

Phase I study of CBM.CD19 chimeric antigen receptor T cell in the treatment of refractory diffuse large B-cell lymphoma in Chinese patients

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 285-294 doi:10.1007/s11684-021-0843-8

Abstract 165 PDF 24

FMO3--TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejection fraction: evidence from an Asian population

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 295-305 doi:10.1007/s11684-021-0857-2

Abstract 228 PDF 23